CS

Cécile SCHIFFER-MANNIOUI

CE Cellectis: 10 patents #9 of 71Top 15%
CS Cellectis Sa: 1 patents #21 of 37Top 60%
📍 Villiers-sur-Marne, FR: #3 of 74 inventorsTop 5%
Overall (All Time): #443,056 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11987639 Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy 2024-05-21
11690873 Universal chimeric antigen receptor T cells specific for CD22 Philippe Duchateau, Anne-Sophie GAUTRON 2023-07-04
11311575 Methods for engineering highly active T cell for immunotherapy Roman Galetto, Agnes Gouble, Stephanie GROSSE, Laurent POIROT, Andrew M. Scharenberg +1 more 2022-04-26
11304975 Methods for engineering allogeneic and highly active t cell for immunotherapy Roman Galetto, Agnes Gouble, Stephanie GROSSE, Laurent POIROT, Andrew M. Scharenberg +1 more 2022-04-19
11077144 CD19 specific chimeric antigen receptor and uses thereof Roman Galetto, Julianne Smith, Andrew M. Scharenberg 2021-08-03
11007224 CD19 specific chimeric antigen receptor and uses thereof Roman Galetto, Julianne Smith, Andrew M. Scharenberg 2021-05-18
10874693 CD19 specific chimeric antigen receptor and uses thereof Roman Galetto, Julianne Smith, Andrew M. Scharenberg 2020-12-29
10759868 Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy 2020-09-01
10752670 Anti-GD3 specific chimeric antigen receptors for cancer immunotherapy Julianne Smith 2020-08-25
10752684 ROR1 (NTRKR1) specific chimeric antigen receptors for cancer immunotherapy 2020-08-25
10544201 ROR1 specific multi-chain chimeric antigen receptor 2020-01-28